Spot palladium fell more than 2.00% in the day and is now reported at $957.09 per ounce.Morgan Stanley lowered the Nike target price from $82.00 to $80.00.Dow opened up 0.1%, S&P 500 rose 0.3%, Nasdaq rose 0.5%, Broadcom rose 18.7%, and Q4 AI revenue increased 220% year-on-year. Furniture retailer RH rose 15.8% and raised its performance forecast. EVgo rose by 9.0% and was supported by a loan of $1.25 billion from the US Department of Energy. Xpeng Motors fell 3.8% and was downgraded to "sell" by UBS.
Russian Defense Ministry: In the past week, the Russian army launched 15 cluster strikes against Ukrainian military enterprises and facilities. The Russian Defense Ministry said that in the past week, the Russian army launched 15 cluster strikes against Ukrainian military enterprises, Ukrainian military security energy facilities and Ukrainian military infrastructure including foreign mercenaries assembly sites.International Finance Association: In November, the net inflow of foreign investment in emerging market bonds and stock portfolios was $19.2 billion; The net outflow of foreign investment in emerging market stock markets was $11.1 billion; Debt inflows reached $30.4 billion.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.
UBS raised the target price of Broadcom from $200 to $220.Jiangxi released a typical case of private equity funds serving the real economy. In recent years, private equity investment institutions have condensed long-term innovative capital and continuously empowered high-quality development. On December 13th, Wan Liangshun, deputy director of the Financial Office of Jiangxi Provincial Party Committee and deputy director of the Provincial Local Financial Administration Bureau, released ten cases of private equity funds serving Jiangxi real economy at the 2024 Yangtze River Economic Belt (Gongqingcheng) Fund Innovation and Development Conference held in Gongqingcheng, Jiangxi. Wan Liangshun introduced that Jiangxi attaches great importance to the development of the private equity industry and clearly requires strengthening guidance to give full play to the role of private equity investment in promoting development. There are 1493 private equity funds in Jiangxi, with an investment of 186.175 billion yuan. Private equity funds have become an important force to attract external capital, help industrial transformation and serve local economy, and the province's fund innovation and development have achieved remarkable results. (SSE)Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).